Aion Therapeutic Inc (TSE:AION) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Aion Therapeutic Inc. has acquired the global licensing rights for I2Pure Corp’s patented molecular iodine, aiming to revolutionize water disinfection through Toppen Health’s advanced filtration systems. The new technology will enable the removal of pathogens, PFAS, and pharmaceuticals, promising cleaner water with the help of I2Pure’s slow-release iodine. The deal includes a cash payment and share payments totaling USD $1.25 million.
For further insights into TSE:AION stock, check out TipRanks’ Stock Analysis page.
